Indica Labs

Indica Labs specializes in developing advanced pathology software solutions, including the HALO image analysis platform, which is used in over 1,000 peer-reviewed publications. HALO offers modules for various applications such as Multiplex IHC, Highplex FL, and Spatial Analysis. HALO AI provides trainable AI for pathology, enabling segmentation, classification, and phenotyping, and includes pre-trained deep-learning networks for nuclear and membrane segmentation. It can be trained to work across different stains like PAMS, Trichrome, H&E, and IHC, and allows for the creation of classifier pipelines by connecting multiple classifiers into a single workflow.

Indica Labs’ HALO AP Dx, a case-centric pathology platform, has received FDA 510(k) clearance and supports primary diagnosis, remote working, and other routine workflows in anatomic pathology. The company’s HALO Clinical AI Solutions include CE-IVD certified deep learning-based screening tools for prostate cancer, non-small cell lung cancer, and primary invasive breast cancer. Indica Labs also offers Pharma Services and AWS-hosted HALO Cloud Services, with deployments in all top 20 Pharma companies.

Additionally, Indica Labs provides HALO Link, a collaborative image management platform for pathology, and has partnerships with companies like ACD, Lunaphore, Akoya Biosciences, Dell, Lunit, Merge by Merative, Xyall, DeepBio, IBEX, Hamamatsu, Molecular Instruments, and Histofy. The company has been recognized as a Top Workplace by the Albuquerque Journal for four consecutive years.